KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) EBT: 2012-2025

Historic EBT for Precigen (PGEN) over the last 14 years, with Sep 2025 value amounting to -$146.3 million.

  • Precigen's EBT fell 510.63% to -$146.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$246.9 million, marking a year-over-year decrease of 74.40%. This contributed to the annual value of -$128.0 million for FY2024, which is 32.86% down from last year.
  • Latest data reveals that Precigen reported EBT of -$146.3 million as of Q3 2025, which was down 449.36% from -$26.6 million recorded in Q2 2025.
  • In the past 5 years, Precigen's EBT registered a high of -$7.7 million during Q3 2022, and its lowest value of -$146.3 million during Q3 2025.
  • Over the past 3 years, Precigen's median EBT value was -$24.0 million (recorded in 2024), while the average stood at -$41.0 million.
  • In the last 5 years, Precigen's EBT skyrocketed by 70.83% in 2022 and then slumped by 510.63% in 2025.
  • Over the past 5 years, Precigen's EBT (Quarterly) stood at -$26.7 million in 2021, then rose by 16.93% to -$22.2 million in 2022, then slumped by 50.61% to -$33.4 million in 2023, then spiked by 40.66% to -$19.8 million in 2024, then crashed by 510.63% to -$146.3 million in 2025.
  • Its EBT was -$146.3 million in Q3 2025, compared to -$26.6 million in Q2 2025 and -$54.2 million in Q1 2025.